Results 1 to 10 of about 33,479 (238)

Efficacy and safety of transarterial chemoembolization combined with donafenib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus: a dual-center, retrospective propensity score-matched analysis. [PDF]

Front Immunol
Zhang Q, Qing H, Lei Z, Xie X.
europepmc   +1 more source

Recorded Early Imaging Responses After Transarterial Chemoembolization Plus Lenvatinib Versus Transarterial Chemoembolization Without Documented Lenvatinib for Unresectable Hepatocellular Carcinoma: A Vietnamese Cohort Study. [PDF]

J Clin Med
Minh VL, Hung NV, Anh PT, Anh PT, Thong PM.   +4 more
europepmc   +1 more source

Comparative evaluation of TACE-RFA versus monotherapies on a background of systemic therapy for recurrent hepatocellular carcinoma: a propensity score-matched analysis. [PDF]

Front Oncol
Zhang W, Ye Z, Wang J, Ren X, Ying L, Wu Y, Wu Z, Xin C, Feng J.   +8 more
europepmc   +1 more source

Impact of TACE combined with targeted and immune therapy on liver function and prognosis in unresectable hepatocellular carcinoma patients: the significance of baseline albumin-bilirubin grade. [PDF]

Ther Adv Med Oncol
Guo Y, Liu X, Sun B, Pu F, Li X, Zheng C, Kan X, Yang F.   +7 more
europepmc   +1 more source

Efficacy and safety of local treatments combined with targeted therapy and immunotherapy versus targeted therapy plus immunotherapy alone in hepatocellular carcinoma: A meta-analysis. [PDF]

Medicine (Baltimore)
Zhang S, Tang Y, Mao X, Sheng T.
europepmc   +1 more source

Safety and efficacy of drug-eluting beads versus conventional bronchial arterial chemoembolization for lung cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Gong Z, Liu Y, Song Y, Li X, Tian Y, Li J, Qi C.   +6 more
europepmc   +1 more source

NLR-based nomogram predicts survival in hepatocellular carcinoma treated with TACE plus targeted immunotherapy. [PDF]

BMC Cancer
Lan HM, Chen L, Yang S, Huang LS, Shen XF, Zhou M, Zhao LY, Hu J.   +7 more
europepmc   +1 more source

Drug-eluting bead TACE improves the efficacy of HAIC combined with molecular-targeted therapy and anti-PD-1 immunotherapy in large hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus: a multicenter retrospective cohort study. [PDF]

BMC Cancer
Ni J, Sun H, Li C, Liu Y, Guo G, Zhou X, Zhou Z, Fan R, Hu H, Fang Z, Xu L.   +10 more
europepmc   +1 more source

Correction: Sequential and synergistic delivery of lipiodol and drug-eluting microspheres circumvents incompatibility to enhance targeted chemoembolization. [PDF]

Front Pharmacol
Frontiers Production Office.
europepmc   +1 more source

Comparison of the efficacy of transarterial chemoembolization combined with different molecular targeted agents and/or immune checkpoint inhibitors for unresectable hepatocellular carcinoma: a systematic review and network meta-analysis. [PDF]

J Gastrointest Oncol
Long JY, Wang XH, Li YR, Huang SR, Li ZJ, Luo Y.   +5 more
europepmc   +1 more source